LOMBARD MED INC - COM (EVAR)

CUSIP: G55598109

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
11,240,976
Share change
-1,115,616
Total reported value
$6,079,000
Price per share
$0.55
Number of holders
12
Value change
-$870,560
Number of buys
2
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G55598109?
CUSIP G55598109 identifies EVAR - LOMBARD MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOMBARD MED INC - COM (EVAR) as of Q2 2017

As of 30 Jun 2017, LOMBARD MED INC - COM (EVAR) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,240,976 shares. The largest 10 holders included Invesco Ltd., Abingworth LLP, SV Health Investors, LLC, CITADEL ADVISORS LLC, Virtu KCG Holdings LLC, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, HSBC HOLDINGS PLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and COMMERCE BANK. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.